Cite
Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.
MLA
Sganga, Stefano, et al. “Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.” Journal of Personalized Medicine, vol. 13, no. 9, Sept. 2023, p. 1339. EBSCOhost, https://doi.org/10.3390/jpm13091339.
APA
Sganga, S., Riondino, S., Iannantuono, G. M., Rosenfeld, R., Roselli, M., & Torino, F. (2023). Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Journal of Personalized Medicine, 13(9), 1339. https://doi.org/10.3390/jpm13091339
Chicago
Sganga, Stefano, Silvia Riondino, Giovanni Maria Iannantuono, Roberto Rosenfeld, Mario Roselli, and Francesco Torino. 2023. “Antibody–Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.” Journal of Personalized Medicine 13 (9): 1339. doi:10.3390/jpm13091339.